Infinity Bio, Inc. filed a Form D with the Securities and Exchange Commission on 2025-08-20.
Infinity Bio, Inc. filed a Form D notice of an exempt securities offering with the SEC on August 20, 2025. The filing reports $5M sold. Its industry group is Other Health Care. It names Joy Nassif (Executive Officer, Director), Caroline Popper (Director), H. Larman (Executive Officer, Director) (SEC Form D, August 20, 2025).
Is this your company?
Sell to companies like Infinity Bio, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-08-20 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Infinity Bio, Inc.
Free to see. No signup.
More on the people and the money behind Infinity Bio, Inc., from the filings we hold.
Other Health Care raises by companies based in Maryland, filed within 90 days of this one, largest first.
Get an email when Infinity Bio, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Infinity Bio, Inc. raises, hires or launches. No email unless you switch it on.
Watch Infinity Bio, Inc. →Get the full cited report on Infinity Bio, Inc.
What the filing shows about Infinity Bio, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Infinity Bio, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Infinity Bio, Inc.'s address as 6200 Seaforth St., Baltimore, MD 21224.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Infinity Bio, Inc. is a registered filer with the SEC (CIK 1982572) and has filed since 2023-06-26. 4 filings are on record, the latest on 2025-08-20.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Infinity Bio, Inc.'s Form D of 2025-08-20 names Joy Nassif, Caroline Popper, H. Larman and 4 more as its officers, directors or promoters.
Its new offerings report $9.50M sold across 3 offerings, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 869 filings in Other Health Care, totalled by week.
Checked away from the filing. What is below does not come from the record on sec.gov.
Discover the antibody reactome. Infinity Bio's MIPSA platform reveals past and ongoing immune responses across comprehensive human, viral, and environmental antigen libraries at population scale.
The title and description the site itself served, answering 200, after redirecting from https://infinitybio.com. Not a cached copy and not the company's directory entry — what was live when we asked.
Joy Nassif is named as Executive Officer and Director on the Form D that Infinity Bio, Inc. filed with the SEC on 20 August 2025, one of 7 people that filing names.
Caroline Popper is named as Director on the Form D that Infinity Bio, Inc. filed with the SEC on 20 August 2025, one of 7 people that filing names.
H. Larman is named as Executive Officer and Director on the Form D that Infinity Bio, Inc. filed with the SEC on 20 August 2025, one of 7 people that filing names.
Bill Campbell is named as Director on the Form D that Infinity Bio, Inc. filed with the SEC on 20 August 2025, one of 7 people that filing names.
Herman Scholtz is named as Director on the Form D that Infinity Bio, Inc. filed with the SEC on 20 August 2025, one of 7 people that filing names.
Matthew Hellauer is named as Director on the Form D that Infinity Bio, Inc. filed with the SEC on 20 August 2025, one of 7 people that filing names.
Malek Fahem is named as Director on the Form D that Infinity Bio, Inc. filed with the SEC on 20 August 2025, one of 7 people that filing names.
7 people named on the filing — 2 holding an executive role and 5 as directors only.
Named as of the 2025-08-20 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Infinity Bio, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Infinity Bio, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Infinity Bio, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Infinity Bio, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Infinity Bio, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-11-01 (infinitybio.com).
Each opens in a new tab, filled in for Infinity Bio, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Health care raises in Baltimore
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/infinity-bio-inc-form-d-25000001